Thrilled to announce positive results with our novel small molecule DB-006 in preclinical studies of atopic dermatitis (AD). AD, or eczema, is a chronic inflammatory skin condition affecting up to 30% of children and 10% of adults worldwide.
https://t.co/mD7RXMsYRJ
XRC Ventures: Science-Backed Skincare Is “The Most Compelling Category” For Beauty Investors.
The market has spoken in favour of science-backed skincare brands in the prices they command. XRC discovered a significant premium for biotechnology brands. https://t.co/ZNB8D4RXss
Many thanks to @LongevityTech for sharing the results of our photoaging study. We see a real need for science-backed interventions that work at a cellular level to reverse signs of premature skin aging and improve overall healthspan. #longevity#antiaging
🚀Exciting progress in skin longevity🚀
In a UV-induced skin aging study designed to mimic day to day sun exposure, DB-006 prevented skin thickening, reduced senescent cells, restored sirtuin/NAD+ levels, and prevented collagen reduction.
#senolytics#antiaging#longevity
Hello #Vancouver business and #investment community. We will be hosting a Meet and Greet for two very exciting Vancouver-based companies @DermBiome and @PanBiome on February 19th at Rodney’s Oyster Bar in Vancouver. Please join! #bctech#biotech
Derm-Biome has begun a 3-month preclinical study in skin aging to assess the protective and preventive activities of 3 compounds in a UV exposure-induced skin aging model designed to mimic the damaging effects of long-term sun exposure.
#dermatology#antiaging#longevity
We are very pleased to announce that we have added acne and acne scarring expert Dr. Jerry Tan to our Scientific Advisory Board.
https://t.co/wVWlUwtLst
#acne#acnescarring#dermtwitter
Researchers looked at 111 benzoyl peroxide acne products and found that 34% percent of them, including products from Proactiv and Clearasil contained benzene at significantly levels higher than what’s considered safe by the FDA. #acne https://t.co/pcMNbbanbI
Derm-Biome is delighted to have been selected to present at BC WEEK 2024.
BC WEEK showcases B.C.-based companies who are interested in trade/investment opportunities from Korea. Participants will include pharmaceutical companies, venture capital, etc. #biotech#skinhealth
The number of children and young people experiencing acne is increasing worldwide. There is a real need for safer and more natural alternatives (psst… we are advancing one!). #acne#skindisease
https://t.co/H1Ac9gHBvy
Itch (pruritus) is the most prevalent, severe, and burdensome symptom of atopic dermatitis (AD), and a clinical unmet need across many other skin conditions. #itch#skindisease#atopicdermatitis
Itch (pruritus) is the most prevalent, severe, and burdensome symptom of atopic dermatitis (AD), and a clinical unmet need across many other conditions. #itch#skindisease
Derm-Biome Pharmaceuticals to develop skincare treatment that promotes skin health and longevity #antiaging#skinhealth#LONGEVITY
https://t.co/nji1VTJQRI
We are very excited to have been awarded an Applied Research and Development grant. We expect great things to come from it!
#aging#inflammation#skindisease
https://t.co/zx4zSzq8oq
We have news!!
Topical application of Derm-Biome’s topical anticancer compound prior to UVB exposure significantly reduced the number and size of precancer lesions, while treatment blocked the progression of squamous cell carcinoma tumors. #skincancer
We have news! Topical application of our compound prior to UVB exposure significantly reduced the number and size of precancer lesions, while treatment blocked the progression of squamous cell carcinoma tumors. #skincancer https://t.co/nXhYHvwU79
With the recent news that benzoyl peroxide products can breakdown into unsafe levels of cancer-causing benzene, there is a real need for acne treatment options that are not only safe, but that are also well tolerated by skin (no side effects!).
We're on it!
#acne#skincare
@SNETCampbell Hi Jamie,
Please follow Derm-Biome so that i can send you a DM. I would love for you to provide a quote for an exciting announcement that we have coming up. Thanks, Gord Eberwein.